418 related articles for article (PubMed ID: 16135669)
1. Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function.
Li SY; Fang CX; Aberle NS; Ren BH; Ceylan-Isik AF; Ren J
J Endocrinol; 2005 Sep; 186(3):491-503. PubMed ID: 16135669
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms.
Li BG; Hasselgren PO; Fang CH
Int J Biochem Cell Biol; 2005 Oct; 37(10):2207-16. PubMed ID: 15927518
[TBL] [Abstract][Full Text] [Related]
3. High glucose induces cardiac insulin-like growth factor I resistance in ventricular myocytes: role of Akt and ERK activation.
Ren J; Duan J; Hintz KK; Ren BH
Cardiovasc Res; 2003 Mar; 57(3):738-48. PubMed ID: 12618235
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.
Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H
Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924
[TBL] [Abstract][Full Text] [Related]
5. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells.
Bishop JD; Nien WL; Dauphinee SM; Too CK
J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical effects of ginkgolide B on cardiomyocyte contractile function in normal and high-glucose environments.
Kim J; Li Q; Fang CX; Ren J
Acta Pharmacol Sin; 2006 May; 27(5):536-42. PubMed ID: 16626507
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
8. Proteasomal degradation of IRS-2, but not IRS-1 by calcineurin inhibition: attenuation of insulin-like growth factor-I-induced GSK-3beta and ERK pathways in adrenal chromaffin cells.
Satoh S; Yanagita T; Maruta T; Nemoto T; Yoshikawa N; Kobayashi H; Tono T; Wada A
Neuropharmacology; 2008 Jul; 55(1):71-9. PubMed ID: 18538359
[TBL] [Abstract][Full Text] [Related]
9. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids.
Shen WH; Boyle DW; Wisniowski P; Bade A; Liechty EA
J Endocrinol; 2005 May; 185(2):275-89. PubMed ID: 15845920
[TBL] [Abstract][Full Text] [Related]
10. Homologous posttranscriptional regulation of insulin-like growth factor-I receptor level via glycogen synthase kinase-3beta and mammalian target of rapamycin in adrenal chromaffin cells: effect on tau phosphorylation.
Nemoto T; Satoh S; Maruta T; Kanai T; Yoshikawa N; Miyazaki S; Yanagita T; Wada A
Neuropharmacology; 2010 Jun; 58(7):1097-108. PubMed ID: 20144629
[TBL] [Abstract][Full Text] [Related]
11. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN.
Mourani PM; Garl PJ; Wenzlau JM; Carpenter TC; Stenmark KR; Weiser-Evans MC
Circulation; 2004 Mar; 109(10):1299-306. PubMed ID: 14993145
[TBL] [Abstract][Full Text] [Related]
12. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors.
Hegner B; Lange M; Kusch A; Essin K; Sezer O; Schulze-Lohoff E; Luft FC; Gollasch M; Dragun D
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):232-8. PubMed ID: 19074484
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with insulin-like growth factor I enhances myocyte contraction by upregulation of Akt-SERCA2a signaling pathway.
Kim SJ; Abdellatif M; Koul S; Crystal GJ
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H130-5. PubMed ID: 18456736
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway.
Lee KW; Yook JY; Son MY; Kim MJ; Koo DB; Han YM; Cho YS
Stem Cells Dev; 2010 Apr; 19(4):557-68. PubMed ID: 19642865
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of phosphatidylinositol 3-kinase and p70S6 kinase blocks osteogenic protein-1 induction of alkaline phosphatase activity in fetal rat calvaria cells.
Shoba LN; Lee JC
J Cell Biochem; 2003 Apr; 88(6):1247-55. PubMed ID: 12647306
[TBL] [Abstract][Full Text] [Related]
16. AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase.
Privratsky JR; Wold LE; Sowers JR; Quinn MT; Ren J
Hypertension; 2003 Aug; 42(2):206-12. PubMed ID: 12847113
[TBL] [Abstract][Full Text] [Related]
17. EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation.
Galbaugh T; Cerrito MG; Jose CC; Cutler ML
BMC Cell Biol; 2006 Sep; 7():34. PubMed ID: 16984645
[TBL] [Abstract][Full Text] [Related]
18. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.
Brunn GJ; Williams J; Sabers C; Wiederrecht G; Lawrence JC; Abraham RT
EMBO J; 1996 Oct; 15(19):5256-67. PubMed ID: 8895571
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
Han S; Khuri FR; Roman J
Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
